Shandong Wohua Pharmaceutical Co Ltd
002107
Company Profile
Business description
Shandong Wohua Pharmaceutical Co Ltd is a China-based company specializing in the field of cardio-cerebral vascular medicine. The company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Naoxueshu oral liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza, among others.
Contact
Fushou East Street
Chuangye Building, 2nd Floor
New and High-Tech Industrial Development Zone
HuaifangShandong261011
CHNT: +86 5368553373
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,089
Stocks News & Analysis
stocks
Are small caps finally back?
Does renewed investor interest point to a structural shift in the underperforming factor?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
The latest update from our Industry Pulse report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,317.20 | 39.00 | 0.42% |
| CAC 40 | 8,206.87 | 51.99 | -0.63% |
| DAX 40 | 24,151.13 | 178.90 | -0.74% |
| Dow JONES (US) | 46,590.41 | 334.33 | -0.71% |
| FTSE 100 | 9,533.90 | 106.91 | 1.13% |
| HKSE | 25,725.24 | 56.53 | -0.22% |
| NASDAQ | 22,740.40 | 213.27 | -0.93% |
| Nikkei 225 | 48,731.51 | 576.28 | -1.17% |
| NZX 50 Index | 13,343.93 | 37.49 | 0.28% |
| S&P 500 | 6,699.40 | 35.95 | -0.53% |
| S&P/ASX 200 | 9,021.90 | 35.70 | 0.40% |
| SSE Composite Index | 3,900.17 | 13.58 | -0.35% |